Use of Grant Amount. (a) Grant Recipient shall use the Grant Amount solely for the Grant Activity and shall not use the Grant Amount for any activity that is inconsistent with, or prohibited by any law, rule or regulation. The Grant Recipient undertakes to independently contact Novartis in the event any part of the Grant Amount has not been used for the Grant Activity so that such amount can be refunded to Novartis without undue delay.
Use of Grant Amount a. Subrecipient shall use the grant amount provided under this Agreement to pay for Eligible Expenses that: (1) are necessary expenditures incurred due to the public health emergency with respect to COVID-19; (2) were not accounted for in the budget most recently approved by Subrecipient as of March 27, 2020; and (3) were incurred during the period that begins on March 1, 2020, and ends on December 30, 2020.
Use of Grant Amount. In accepting any portion of the Grant Amount, Grantee agrees that it shall expend the grant funds only to perform and complete the Grant Project, including purchasing the materials, equipment or other goods and/or services required to complete the Grant Project.
Use of Grant Amount a. The grant funds provided are federal funds and subject to the Single Audit Act of 1984. The following information is provided in accordance with the Single Audit Act. Award Amount Up to $14,000 Subrecipient Name City of Garden Xxxxx XXX UEI Number Y1NYWMLHKNM7 Awarding County Agency OC Community Resources County Contact Information Xxxxx Xxxxxxx Federal Award Identification Number (XXXX) SLFRP1607 Assistance Listing Number (ALN) 21.027 / Coronavirus State and Local Fiscal Recovery Funds Awarding Federal Agency US Treasury Department Indirect Cost Rate 10% MTDC or Federally Approved Rate Whether Award is R&D No MA-012-23010035 DocuSign Envelope ID: 68A47D0D-6AF5-4C36-9DE2-0852C5798121
Use of Grant Amount a. The grant funds provided are state funds and subject to state law requirements.
Use of Grant Amount. City must use the grant amount provided under this MOU to pay for eligible expenses that: (1) are necessary expenditures incurred due to the public health emergency with respect to COVID-19; (2) were not accounted for in the budget most recently approved by City as of March 27, 2020; and (3) were incurred during the period that begins on March 1, 2020, and ends on December 30, 2020. CFDA# XXXX# Program/ Service Title Federal Funding Agency Federal Award Date Federal Award Indirect Rate Amount R&D Award (Y/N) 21.019 SLT0123 Coronavirus Relieft Fund US Department of Treasury April 22, 2020 10% $544,133,764.90 N City must utilize the grant amount in accordance with all Federal and State laws, including but not limited to 42 U.S.C. § 801, subsection (d), and all applicable regulations and guidelines, including guidance issued by the Department of Treasury regarding costs that are payable from Coronavirus Relief Funds, which includes but is not limited to Guidance for State, Territorial, Local, and Tribal Governments dated April 22, 2020 (Exhibit A) and Coronavirus Relief Fund Frequently Asked Questions Updated as of May 28, 2020 (Exhibit B).
Use of Grant Amount. DK1906694767
Use of Grant Amount. City must use the grant amount provided under this MOU to pay for eligible expenses that: (1) are necessary expenditures incurred due to the public health emergency with respect to COVID-19; (2) were not accounted for in the budget most recently approved by City as of March 27, 2020; and (3) were incurred during the period that begins on March 1, 2020, and ends on December 30, 2020. City must utilize the grant amount in accordance with all Federal and State laws, including but not limited to 42 U.S.C. § 801, subsection (d), and all applicable regulations and guidelines, including guidance issued by the Department of Treasury regarding costs that are payable from Coronavirus Relief Funds, which includes but is not limited to Guidance for State, Territorial, Local, and Tribal Governments dated April 22, 2020 (Exhibit A) and Coronavirus Relief Fund Frequently Asked Questions Updated as of May 28, 2020 (Exhibit B).
